DNA vaccines: an historical perspective and view to the future
MA Liu - Immunological reviews, 2011 - Wiley Online Library
This review provides a detailed look at the attributes and immunologic mechanisms of
plasmid DNA vaccines and their utility as laboratory tools as well as potential human …
plasmid DNA vaccines and their utility as laboratory tools as well as potential human …
Prime-boost vaccine strategy against viral infections: Mechanisms and benefits
K Kardani, A Bolhassani, S Shahbazi - Vaccine, 2016 - Elsevier
The essential goal of vaccination is to generate potent and long-term protection against
diseases. Among different vaccine modalities, prime-boost vaccine strategies could …
diseases. Among different vaccine modalities, prime-boost vaccine strategies could …
[HTML][HTML] A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity
Recombinant adenoviruses are among the most promising tools for vaccine antigen
delivery. Recently, the development of new vectors has focused on serotypes to which the …
delivery. Recently, the development of new vectors has focused on serotypes to which the …
Heterologous prime–boost vaccination
S Lu - Current opinion in immunology, 2009 - Elsevier
An effective vaccine usually requires more than one time immunization in the form of prime–
boost. Traditionally the same vaccines are given multiple times as homologous boosts. New …
boost. Traditionally the same vaccines are given multiple times as homologous boosts. New …
[HTML][HTML] Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Induction of antigen-specific CD8+ T cells offers the prospect of immunization against many
infectious diseases, but no subunit vaccine has induced CD8+ T cells that correlate with …
infectious diseases, but no subunit vaccine has induced CD8+ T cells that correlate with …
Technologies for enhanced efficacy of DNA vaccines
F Saade, N Petrovsky - Expert review of vaccines, 2012 - Taylor & Francis
Despite many years of research, human DNA vaccines have yet to fulfill their early promise.
Over the past 15 years, multiple generations of DNA vaccines have been developed and …
Over the past 15 years, multiple generations of DNA vaccines have been developed and …
HLA and infectious diseases
JM Blackwell, SE Jamieson… - Clinical microbiology …, 2009 - Am Soc Microbiol
Following their discovery in the early 1970s, classical human leukocyte antigen (HLA) loci
have been the prototypical candidates for genetic susceptibility to infectious disease …
have been the prototypical candidates for genetic susceptibility to infectious disease …
[HTML][HTML] A review of malaria vaccine clinical projects based on the WHO rainbow table
L Schwartz, GV Brown, B Genton, VS Moorthy - Malaria journal, 2012 - Springer
Abstract Development and Phase 3 testing of the most advanced malaria vaccine, RTS,
S/AS01, indicates that malaria vaccine R&D is moving into a new phase. Field trials of …
S/AS01, indicates that malaria vaccine R&D is moving into a new phase. Field trials of …
Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1
Background. Influenza A viruses cause occasional pandemics and frequent epidemics.
Licensed influenza vaccines that induce high antibody titers to the highly polymorphic viral …
Licensed influenza vaccines that induce high antibody titers to the highly polymorphic viral …
[HTML][HTML] Experimental human challenge infections can accelerate clinical malaria vaccine development
RW Sauerwein, M Roestenberg… - Nature Reviews …, 2011 - nature.com
Malaria is one of the most frequently occurring infectious diseases worldwide, with almost 1
million deaths and an estimated 243 million clinical cases annually. Several candidate …
million deaths and an estimated 243 million clinical cases annually. Several candidate …